Open original FDA record ↗Recall record
- FDA identifier
- Z-1021-2023
- Company in FDA record
- Biokit, S.A.
- FDA classification date
- Jan 26, 2023
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
HSV-2 rapid test may report false positive results.
Source facts
- Action
- On 9/28/22, Werfen Field Action notices were emailed to customers who were asked to 1) Stop using and discard affected kits, 2) Complete and return the tracking form provided with the notice to oem-complaints@werfen.com, 3) Forward the notice to all affected facilities. On 2/10/23, Werfen Field Action notices were emailed to additional customers informing them of an additional affected lot. On 3/13/23, Werfen Field Action notices were emailed to an additional customer informing them of an additional affected lot. On 4/11/23, Werfen Field Action notices were emailed to an additional customer informing them of an additional affected lot.
- Initiated
- 2022-09-28
- Root cause
- Nonconforming Material/Component
- Distribution
- US Nationwide distribution in the states of NY, CA, IN, NC, VA.
- Recall number
- Z-1021-2023
- Recall status
- Open, Classified
- CDRH record ID
- 197600
- FDA classified
- 2023-01-26
- Recall event number
- 91384